Arch Therapeutics Alpha and Beta Analysis
| ARTHDelisted Stock | USD 0.0001 0.00 0.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Arch Therapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Arch Therapeutics over a specified time horizon. Remember, high Arch Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Arch Therapeutics' market risk premium analysis include:
Beta (49.46) | Alpha 37.51 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Arch |
Arch Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Arch Therapeutics market risk premium is the additional return an investor will receive from holding Arch Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Arch Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Arch Therapeutics' performance over market.| α | 37.51 | β | -49.46 |
Arch Therapeutics Fundamentals Vs Peers
Comparing Arch Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Arch Therapeutics' direct or indirect competition across all of the common fundamentals between Arch Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Arch Therapeutics or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Arch Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Arch Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Arch Therapeutics to competition |
| Fundamentals | Arch Therapeutics | Peer Average |
| Return On Equity | -40.15 | -0.31 |
| Return On Asset | -1.14 | -0.14 |
| Operating Margin | (364.73) % | (5.51) % |
| Current Valuation | 12.54 M | 16.62 B |
| Shares Outstanding | 249.94 M | 571.82 M |
| Shares Owned By Insiders | 14.58 % | 10.09 % |
| Price To Earning | (16.36) X | 28.72 X |
Arch Therapeutics Opportunities
Arch Therapeutics Return and Market Media
The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About Arch Therapeutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Arch or other pink sheets. Alpha measures the amount that position in Arch Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Arch Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Arch Therapeutics' short interest history, or implied volatility extrapolated from Arch Therapeutics options trading.
Build Portfolio with Arch Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Consideration for investing in Arch Pink Sheet
If you are still planning to invest in Arch Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Arch Therapeutics' history and understand the potential risks before investing.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |